72 related articles for article (PubMed ID: 38483604)
1. Brain-Type Glycogen Phosphorylase (PYGB) in the Pathologies of Diseases: A Systematic Review.
Yang C; Wang H; Shao M; Chu F; He Y; Chen X; Fan J; Chen J; Cai Q; Wu C
Cells; 2024 Feb; 13(3):. PubMed ID: 38334681
[TBL] [Abstract][Full Text] [Related]
2. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
[TBL] [Abstract][Full Text] [Related]
4. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p.
Zhou Y; Jin Z; Wang C
Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092
[TBL] [Abstract][Full Text] [Related]
5. PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Zhang S; Zhou Y; Zha Y; Yang Y; Wang L; Li J; Jin W
Mol Med Rep; 2018 Jul; 18(1):715-722. PubMed ID: 29845265
[TBL] [Abstract][Full Text] [Related]
6. Silencing of PYGB suppresses growth and promotes the apoptosis of prostate cancer cells via the NF‑κB/Nrf2 signaling pathway.
Wang Z; Han G; Liu Q; Zhang W; Wang J
Mol Med Rep; 2018 Oct; 18(4):3800-3808. PubMed ID: 30106110
[TBL] [Abstract][Full Text] [Related]
7. Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Cui G; Wang H; Liu W; Xing J; Song W; Zeng Z; Liu L; Wang H; Wang X; Luo H; Leng X; Shen S
Front Cell Dev Biol; 2020; 8():566494. PubMed ID: 33324633
[TBL] [Abstract][Full Text] [Related]
8. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Zhan Y; Chen R; Wang T; Shan S; Zhu H
Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613
[TBL] [Abstract][Full Text] [Related]
9. Signalling in pancreatic cancer: from pathways to therapy.
Zhou K; Liu Y; Yuan S; Zhou Z; Ji P; Huang Q; Wen F; Li Q
J Drug Target; 2023 Dec; 31(10):1013-1026. PubMed ID: 37869884
[TBL] [Abstract][Full Text] [Related]
10. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer.
Ji Q; Li H; Cai Z; Yuan X; Pu X; Huang Y; Fu S; Chu L; Jiang C; Xue J; Zhang X; Li R
Int J Biol Sci; 2023; 19(6):1894-1909. PubMed ID: 37063425
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer: Advances and challenges.
Halbrook CJ; Lyssiotis CA; Pasca di Magliano M; Maitra A
Cell; 2023 Apr; 186(8):1729-1754. PubMed ID: 37059070
[TBL] [Abstract][Full Text] [Related]
12. Imaging glucose metabolism to reveal tumor progression.
Meng Y; Sun J; Zhang G; Yu T; Piao H
Front Physiol; 2023; 14():1103354. PubMed ID: 36818450
[No Abstract] [Full Text] [Related]
13. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.
Szklarczyk D; Kirsch R; Koutrouli M; Nastou K; Mehryary F; Hachilif R; Gable AL; Fang T; Doncheva NT; Pyysalo S; Bork P; Jensen LJ; von Mering C
Nucleic Acids Res; 2023 Jan; 51(D1):D638-D646. PubMed ID: 36370105
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the cancer cell line metabolic landscape.
Shorthouse D; Bradley J; Critchlow SE; Bendtsen C; Hall BA
Mol Syst Biol; 2022 Nov; 18(11):e11006. PubMed ID: 36321551
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance.
Sherman MH; Beatty GL
Annu Rev Pathol; 2023 Jan; 18():123-148. PubMed ID: 36130070
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
